← Back to Search

Iron Supplement

Ferumoxytol injection for Anemia (AMAGFeraheme Trial)

Phase 4
Waitlist Available
Led By Stuart Katz, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 6
Awards & highlights

AMAGFeraheme Trial Summary

This trial is testing a new way to give iron supplements to people who have had a heart device put in, to see if it's better than the old way.

AMAGFeraheme Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of Patients Who Successfully Complete Ferumoxytol Injection Treatment

AMAGFeraheme Trial Design

1Treatment groups
Experimental Treatment
Group I: Ferumoxytol injection treatmentExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,368 Previous Clinical Trials
839,725 Total Patients Enrolled
Stuart Katz, MDPrincipal InvestigatorNew York Langone Medical Center
9 Previous Clinical Trials
957 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could I potentially be accepted into this clinical research study?

"Eligibility requirements for this trial necessitate that potential participants must display anemia and be between 19 and 110 years old. Additionally, the team is currently looking to accept no more than 20 volunteers into the study."

Answered by AI

Have there been any prior experiments involving Ferumoxytol injection?

"Currently, there are 15 active studies that investigate the use of Ferumoxytol injection with 4 trials in their third phase. Most of these clinical investigations take place in New york City while 40 sites across America host similar research."

Answered by AI

Does Ferumoxytol injection pose any risks to patients?

"Ferumoxytol injection is a licensed medication, which led to it receiving a 3 out of 3 safety rating according to our team's assessment."

Answered by AI

What is the cap on enrollees for this clinical trial?

"Affirmative. Data from clinicaltrials.gov indicates that recruitment for the trial began on January 15th 2020 and recently resumed activity August 11th 2022. A total of 20 participants are expected to be accepted across 1 medical centre."

Answered by AI

Is this experiment currently recruiting participants?

"This research protocol is in the process of recruiting participants. It was first advertised on 15th January 2020 and underwent its last review on 11th August 2022, as per clinicaltrials.gov's records."

Answered by AI

Are any individuals over 40 being included in this experiment?

"Patients that are between 19 years and 110 years old can join this medical trial."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Study to Assess Feasibility and Safety of Iron Repletion With Feraheme in Iron Deficient Patients With Durable Ventricular Assist Device Support
2020. "Study to Assess Feasibility and Safety of Iron Repletion With Feraheme in Iron Deficient Patients With Durable Ventricular Assist Device Support". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04080908.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top